Brutalist Biotech

• Alphabet’s SandboxAQ teams up with Swiss biotech to develop mRNA cancer vaccine (34m)
• NIH fires exec amid probe into wife’s role in $3.3M contract: report (1h)
• Kezar sees hepatitis hold lifted, hints at resurrecting lupus program (2h)

• 33 states pick up CMS program to pay for sickle cell gene therapies (1h)
• Cancer drugmaker LaNova to sell to China’s Sino Biopharm (1d)
• Hengrui, Kailera say dual-acting obesity shot succeeds in China study (1d)

• PureTech CEO leaves just one week after longtime chair steps down (36m)
• RFK replaces two top aides at HHS, including chief of staff (37m)
• Prime Medicine CSO departs, reveals new funding; FDA lifts partial hold on Kezar drug (57m)

• AstraZeneca’s Amyloidosis Asset Stumbles in Late-Stage Trials (44m)
• J&J Raises 2025 Outlook as Oncology and Neuroscience Drive Q2 Growth (2h)
• GSK’s Blenrep DREAMMs Turn Fitful as FDA Questions Comeback in Multiple Myeloma (2h)

Bio IT World

• A Popular Alzheimer’s Biomarker Found at High Levels in Newborns (10h)
• Pharma Companies Finding Their Way with AI (1d)
• Trends from the Trenches: What a TV Scientist Knows About Teaching Science (6d)

• Protein structure competition, of AlphaFold fame, nearing deal to replace lost NIH funding (50m)
• An unusual use for AI in medical education (1h)
• FDA questions safety of GSK’s multiple myeloma drug (1h)

• Google Expands MedGemma Collection With Multimodal Health AI Models for Open Development (6d)
• Xaira Therapeutics Appoints Biotech Exec Behind Belharra and Ambys as President and COO to Scale AI-Driven Drug Discovery Platform (7d)
• NIH To End Funding for Animal-Only Studies, Backing Shift to New Approach Methodologies (1w)

• Eight rare autoimmune diseases biotechs are fighting to treat (2h)
• Serial acquirer Concentra Biosciences on a buyout spree in 2025 (1d)
• Top biotech books of all time (2d)

• New Voltage Sensing Technology Images Brain Activity to Understand Disease (33m)
• NIST Releases Pancreatic Cancer Panacea of Genomic Content (3h)
• NIST Releases Entire Genetic Content of Pancreatic Cancer Cell Analyzed Using Multiple Technologies (3h)

• Carotuximab Combo Proves Safe for Advanced Prostate Cancer (34m)
• How Outpatient CAR T-Cell Therapy May Be Safer For Patients (2h)
• How Love Helped Me Face Leukemia and Keep Living (18h)

Contract Pharma*

• Tobin Scientific Opens New cGMP Warehouse in Wilmington, MA (1h)
• Satellos Appoints Wildon Farwell as Chief Medical Officer (1h)
• LogiCare3PL Partners with ChiRhoClin (2h)

• North East NHS launches digital platform to tackle chronic kidney disease (2h)
• Proximie and HistoSonics partner to transform liver tumour treatment in US (2h)
• NHS England secures access to new cystic fibrosis treatment ALYFTREK (1d)

• The Crisis That Unites Us: Healthcare Costs Are Breaking Everyone (1h)
• Men’s Health is an Overlooked Part of Family Health: Why Employers Should Rethink Their Benefits Strategy (2h)
• Using Case Management to Improve Maternal Health Outcomes (4h)

• How to successfully work with difficult people (3h)
• Waters to acquire BD flow cytometry business in a deal valued at $17.5 billion (20h)
• AI tool uses team approach to solve quantum chemistry problems (1d)

The Pharma Letter*

• Lilly’s $1 billion CRISPR bet: what Verve means for gene editing (1h)
• PureTech CEO Bharatt Chowrira steps down (2h)
• Number of patent disputes continue to grow in Russian pharma market (2h)

• Across Cancer Types, Trispecific Antibodies Show Promise in Early Result (34m)
• Dual Bispecific Therapy Shows Promise in High-Risk Multiple Myeloma With EMD (1h)
• Addressing Financial Toxicity and Food Insecurity in Cancer Care (2h)

• Lawsuits rain down on Hims & Hers after Novo Nordisk partnership ends (2h)
• Johnson & Johnson surprises with higher Darzalex sales – share price rises (4h)
• EU Commission makes final verdict in price cartel case (4h)

• Dual Antibody Conjugates For Twice the Excitement (17h)
• Sulfonate Esters in Drug Substances: Real Problem or Not? (1d)
• Senolytic Update (5d)

• NHS trust rolls out digital health tool for kidney disease (2h)
• FDA fast-tracks Sanofi's gene therapy for eye disease GA (4h)
• AstraZeneca sifts for efficacy crumbs in amyloidosis trial (5h)

• Guide: 10 practical tips for reliable MEA experiments in preclinical neuroscience (1h)
• Webinar: The strategic power of pathology and AI for biopharma RD (3h)
• 10 practical tips for reliable MEA experiments in preclinical neuroscience (5h)

Google News Biotech

• MEPs signal backing for public-private deals amid biotech report rewrite - Euractiv (35m)
• Alphabet’s SandboxAQ teams up with Swiss biotech to develop mRNA cancer vaccine - Fierce Biotech (35m)
• Generation Bio Surges 17% Amid Biotech Breakthrough Buzz – What’s Next? - AInvest (1h)